Search company, investor...

Leversense

leversense.com

Stage

Seed - II | Alive

Total Raised

$400K

Last Raised

$400K | 13 yrs ago

About Leversense

Leversense is currently developing next generation diagnostic biosensor technology that is extremely sensitive directly in complex matrixes such as whole blood, serum, urine, or milk.

Headquarters Location

980 Garrett Mill Road

Newtown Square, Pennsylvania, 19073,

United States

Missing: Leversense's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Leversense's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Leversense Patents

Leversense has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/17/2010

1/8/2013

Analytical chemistry, Molecular biology, Chromatography, Spectroscopy, Biotechnology

Grant

Application Date

2/17/2010

Grant Date

1/8/2013

Title

Related Topics

Analytical chemistry, Molecular biology, Chromatography, Spectroscopy, Biotechnology

Status

Grant

Leversense Frequently Asked Questions (FAQ)

  • Where is Leversense's headquarters?

    Leversense's headquarters is located at 980 Garrett Mill Road, Newtown Square.

  • What is Leversense's latest funding round?

    Leversense's latest funding round is Seed - II.

  • How much did Leversense raise?

    Leversense raised a total of $400K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.